SOURCE: Earth Science Tech, Inc.

Earth Science Tech, Inc.

November 03, 2014 07:00 ET

Earth Science Tech Enters Stage 2 of Research on Its Hemp Oil Enriched With CBD (Cannabidiol) on Immune Cells and Announces Multiple Patents and Clinical Trials of the CBD-Cannabinoid Compounds

BOCA RATON, FL--(Marketwired - November 03, 2014) - Earth Science Tech, Inc. (OTCQB: ETST) ("ETST" or "the Company"), a unique biotechnology company focused on nutraceuticals, bioceuticals and dietary supplements, today announced it has entered stage 2 of research on the effectiveness of its Hemp Oil Enriched with CBD (Cannabidiol) on Immune Cells at the College of Mathematics and Science at the University of Central Oklahoma (UCO) with the assistant dean Dr. Wei Chen. As initially stated ETST will continue to strive in order to be at the forefront of all natural products to increase overall health and wellness for consumers worldwide. To this end ETST is going to continue to research various formulations using all natural products to obtain additional research, testing, studies and claims. Furthermore ETST looks forward to updating the market with the results of the immune cell testing in the near term. On another note and as previously stated, ETST is very encouraged with the positive preliminary test results on the effects of ETST Hemp Oil Enriched with CBD-Cannabidiol on Animal Breast Cancer Cells and on Normal Cells. ETST recently announced that the initial report from the Sponsored Research Agreement with the University of Central Oklahoma and its lead investigator Dr. Wei R. Chen showed the effects of its Hemp Oil Enriched with CBD-Cannabidiol (provided by Earth Science Tech, Inc.) on animal breast cancer cells and on normal cells. The results of this preliminary study indicate that with appropriate dose, in this case with ETST proprietary Hemp Oil Enriched with CBD-Cannabidiol dose, Hemp Oil Enriched with CBD-Cannabidiol can inhibit the proliferation of cancer cells more than that of normal cells. This purpose of the experiment with the University of Central Oklahoma and its lead investigator Dr. Wei R. Chen was to investigate the effects of ETST Hemp oil Enriched with CBD-Cannabidiol on animal breast cancer cells and on normal cells. If Hemp Oil Enriched with CBD-Cannabidiol has the same effect in vivo, it may help with cancer patients. However, further experiments are needed to investigate the effects of Hemp Oil Enriched with CBD-Cannabidiol on different cells, particularly on immune cells. Therefore ETST has begun testing with immune cells and is excited to see what the future may bring us and consumers worldwide. 

On October 20, 2014, ETST entered into an Assignment of Patent Application with Dr. Wei R. Chen for assignment of a patent pending under Application number 62061577 entitled "Cannabidols Composition and Uses Thereof." ETST has secured, and was assigned, this new patent for Hemp Oil Enriched with CBD (Cannabidiol) and Hemp Oil Enriched with Proprietary Additives. Furthermore, ETST intends to invest upwards of $600,000.00 in order to secure and develop multiple patents and conduct clinical trials of the Cannabidol Compounds. The company feels this will allow it to be at the forefront of the Hemp Oil and CBD (Cannabidiol) markets. The company is currently working with Allen F. Bennett, P.A. of Bennett Intellectual Property. Dr Katz stated, "The research to date has shown better than expected results, as we continue to test and develop new products with our Hemp Oil Enriched with CBD. I am very pleased of the efforts and developments with Dr. Wei Chen and the College of Mathematics and Science at the University of Central Oklahoma (UCO). We hope to be able to make a significant impact in the wellness and nutrition markets." 

Dr. Wei R. Chen has also done extensive work in the area of laser treatment of breast cancer and is working with a foreign drug company to advance and exploit the technology under development. Dr. Chen is a world renowned scientist, researcher and university professor whose laboratory is prominent in various areas including the application of CBD (Cannabidiol). ETST is in the business of manufacturing and marketing products which utilize the CBD component of hemp oil for nutritional and palliative purposes. ETST wants to let its shareholders know that the filing of this patent application and assignment to ETST is just the beginning of many other great things to come. ETST looks to build a strong intellectual property portfolio. The company looks forward to continuing to grow as a unique biotechnology company in order to help consumers Worldwide with their overall Health and Wellness through cutting edge Nutraceuticals and Dietary supplements.

ETST High Grade CBD (Cannabidiol) Rich Hemp Oil is natural and formulated using a wide array of cutting-edge technologies. ETST is capable of supplying and offering its High Grade CBD Rich Hemp Oil in all 50 states and over 40 countries as a nutritional and dietary supplement designed to support overall health and wellness. ETST invites all interested parties to contact the company directly at info@earthsciencetech.com in regards to securing its All Natural High Grade CBD (Cannabidiol) Rich Hemp Oil for wholesale, resale, private labeling or distribution. Furthermore, ETST is now offering the availability for the Health and Wellness markets, consumers and its shareholders to try its High Grade CBD Rich Hemp Oil in small quantities at wholesale type prices online at http://www.earthsciencetech.com/cbd-rich-hemp-oil/.

ETST is open to forming new strategic partnerships, joint ventures and/or supplying vendors, resellers and third party distribution companies with its High Grade CBD Rich Hemp Oil at wholesale prices in order to better help supply the health and wellness markets on a large scale. The company feels it can grow at a much faster pace by focusing on becoming a large wholesale distributor of its High Grade CBD Rich Hemp Oil and by aligning itself with key strategic partners and third party resellers that are already well diversified in the Health and Wellness markets. ETST's High Grade CBD Rich Hemp Oil is All Natural and derived completely from the federally legal industrial hemp plant. Industrial Hemp (Hemp) is not marijuana and will not get you 'high' and it does not require a medical license of any kind to authorize purchase. It is lab tested multiple times during the manufacturing process, from seed to shelf. This also includes being tested for CBD content, other Cannabinoid content, yeast/mold/fungus, and bacteria like E. coli to ensure safety and top quality. Cannabidiol (CBD) is a naturally occurring constituent of the hemp plant (seed, stem and stalk). It is the most abundant non-psychoactive cannabinoid in hemp (cannabis), and is commonly used as a dietary supplement to support general health, immune system support, nervous system and much more. Research shows that many scientists and doctors think the cannabinoids work synergistically to support the whole human endo-cannabinoid system (internal and natural human cannabinoid system). Furthermore, many scientists and doctors believe the endo-cannabinoid system plays a fundamental role in the functioning of many of the major human physiological systems, including the immune and nervous systems. Hemp oil contains CBD -- a non-psychoactive compound of the plant. There are millions of hemp oil consumers around the world and this number is rapidly rising with an increasing number of reports and studies showing a variety of benefits of hemp oil. ETST does not grow, sell or distribute any substances that violate United States Law or the controlled substance act. ETST does sell and distribute hemp based products.

ABOUT ETST (www.earthsciencetech.com): ETST is a unique Biotechnology company focused on delivering cutting edge Nutraceuticals, Bioceuticals and Dietary Supplements designed for excellence in the areas of Health, Wellness, Sports and Alternative Medicine and to improving the quality of life for Consumers Worldwide. ETST is also dedicated to providing Natural Alternatives to prescription medications through Nutritional Supplements and Dietary Supplements that help improve common disorders and illnesses. This may include products such as CBD (Cannabidiol) as a natural constituent of Hemp Oil, Vitamins, Minerals, Herbs, Botanicals, Personal Care Products, Homeopathies, Functional Foods and other products. These products may be in various formulations and delivery systems including (but not limited to) capsules, tablets, soft gels, chewables, liquids, creams, sprays, powders, and whole herbs.

ETST is focused on researching and developing innovative Hemp extracts and to make them accessible Worldwide. ETST plans to be the premier supplier of the highest quality Hemp Oil Enriched with High Grade CBD (Cannabidiol). ETST primary goal is to advance different High Quality Hemp extracts with a broad profile of Cannabinoids and additional natural molecules found in Industrial Hemp and to identify their distinct properties. The company is dedicated in offering its consumers the finest and purest quality All Natural CBD Rich Hemp oil while never compromising on quality. This High Grade CBD (Cannabidiol) Rich Hemp oil is classified as "food based" and therefore perfectly permissible in all 50 states and more than 40 countries. Cannabinoids (Cannabidiol/CBD) are natural constituents of the Hemp plant and CBD is derived from Hemp stalk and seed. Hemp oil is a well-known dietary supplement and the naturally occurring CBD possesses no psychoactive qualities and presents a continuing stream of overwhelming evidence of significant Health and Wellness benefits. With no psychoactive ingredient, CBD is a ready-for-market Hemp-based Nutraceutical. According to scientific and clinical studies, CBD has the potential to help a range of conditions including epilepsy, diabetes, rheumatoid arthritis, chronic pain, alcoholism, schizophrenia, PTSD, antibiotic-resistant infections, and various neurological disorders (Source: National Center for Biotechnology Information http://www.ncbi.nlm.nih.gov). CBD has moreover exhibited Neurogenic and Neuroprotective effects and its anti-cancer properties are currently being investigated at several academic research centers in the United States and abroad. The United States Food and Drug Administration (FDA) currently considers non-THC hemp based cannabinoids, including CBD, to be "food based" and therefore saleable. These new non-psychoactive CBD-rich hemp oil products that ETST has geared up to market and distribute are beyond reproach and available to consumers in all 50 states and in more than 40 countries. CBD (cannabidiol), a naturally occurring constituent of the industrial hemp plant, promotes and supports the nutritional health of aging bodies in particular. Source: US Government Patent #6,630,507 "Cannabinoids as antioxidants and neuroprotectants."

FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE: These statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.

FORWARD LOOKING DISCLAIMER: This release contains forward-looking statements that involve risks and uncertainties. Readers are referred to the Securities and Exchange Commission filings filed by the Company on EDGAR at http://www.sec.gov/edgar.shtml, specifically the most recent reports which identify important risk facts that could cause actual results to differ from those contained in the forward-looking statements. The Company undertakes no obligation to review or confirm analysts' expectations or estimates or to publicly release any revisions to any forward-looking statements. The information contained in this press release should not be construed as any indication of the Company's future stock price, its revenues or results of operations.

Contact Information